Gilles Favre Selected Research

Gilles Favre Research Topics

Disease

46	Neoplasms (Cancer) 01/2021 - 09/2002
13	Melanoma (Melanoma, Malignant) 02/2019 - 07/2004
11	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2003
10	Lung Neoplasms (Lung Cancer) 05/2020 - 04/2004
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 11/2009
8	Carcinogenesis 01/2021 - 04/2004
5	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2009
5	Glioblastoma (Glioblastoma Multiforme) 06/2013 - 12/2003
5	Glioma (Gliomas) 04/2009 - 07/2002
4	Hypoxia (Hypoxemia) 02/2015 - 12/2003
3	Adenocarcinoma of Lung 01/2020 - 01/2016
3	Genomic Instability 11/2019 - 08/2014
3	Circulating Neoplastic Cells 01/2018 - 01/2016
3	Ovarian Neoplasms (Ovarian Cancer) 04/2010 - 01/2008
2	Disease Progression 01/2020 - 02/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 02/2016
2	Hypersensitivity (Allergy) 06/2015 - 01/2014
2	Atherosclerosis 10/2006 - 03/2004
1	Residual Neoplasm 03/2020
1	Adenocarcinoma 12/2014
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2014
1	Oncogene Addiction 02/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2006
8	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2014
8	Monomeric GTP-Binding ProteinsIBA 07/2019 - 12/2003
7	Biomarkers (Surrogate Marker)IBA 11/2019 - 09/2010
5	Guanosine Triphosphate (GTP)IBA 01/2021 - 03/2008
5	Tamoxifen FDA LinkGeneric 02/2010 - 09/2003
5	TransferasesIBA 02/2010 - 09/2003
4	Tyrosine Kinase InhibitorsIBA 05/2022 - 01/2017
4	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2021 - 02/2008
4	GTP Phosphohydrolases (GTPases)IBA 01/2019 - 09/2010
4	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2013 - 07/2002
4	tipifarnib (R115777)IBA 06/2013 - 07/2002
4	Estrogen ReceptorsIBA 01/2013 - 11/2004
3	Messenger RNA (mRNA)IBA 07/2019 - 07/2012
3	LigandsIBA 03/2017 - 08/2004
3	Pharmaceutical PreparationsIBA 08/2014 - 07/2002
3	Small Interfering RNA (siRNA)IBA 01/2014 - 01/2006
3	IntegrinsIBA 06/2013 - 07/2008
3	Biological ProductsIBA 11/2009 - 12/2003
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2009 - 09/2002
2	ErbB Receptors (EGF Receptor)IBA 05/2022 - 06/2012
2	Circulating Tumor DNAIBA 05/2020 - 01/2016
2	Cell-Free Nucleic AcidsIBA 03/2020 - 10/2016
2	AntibodiesIBA 02/2019 - 03/2008
2	micaIBA 03/2017 - 01/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 06/2011
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 02/2016 - 08/2014
2	Monoclonal AntibodiesIBA 01/2016 - 08/2015
2	AntigensIBA 01/2016 - 12/2005
2	RNA (Ribonucleic Acid)IBA 01/2016 - 04/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2015 - 02/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013 - 12/2007
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2012 - 02/2010
2	Hormones (Hormone)IBA 02/2010 - 09/2003
2	Histocompatibility Antigens Class IIBA 02/2010 - 12/2005
2	CholesterolIBA 08/2004 - 03/2004
2	Selective Estrogen Receptor Modulators (SERM)IBA 08/2004 - 03/2004
1	Diphosphonates (Bisphosphonates)IBA 01/2020
1	osimertinibIBA 01/2020
1	Gefitinib (Iressa)FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 11/2019
1	Antineoplastic Agents (Antineoplastics)IBA 07/2019
1	Decitabine FDA Link 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	NivolumabIBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Threonine (L-Threonine)FDA Link 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 03/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2016
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 03/2016
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 03/2016
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2016
1	Circulating MicroRNAIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 08/2015
1	Chemokine CXCL12IBA 08/2015
1	VemurafenibIBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Oxygen (Dioxygen)IBA 02/2015
1	fasudil (AT 877)IBA 01/2015
1	Fas Ligand Protein (Fas Ligand)IBA 01/2015
1	fas Receptor (CD95 Antigen)IBA 01/2015
1	CamptothecinIBA 08/2014
1	Histones (Histone)IBA 01/2014
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 06/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	Mevalonic Acid (Mevalonate)IBA 01/2013
1	Staphylococcal Protein A (Protein A)IBA 01/2013

Therapy/Procedure

12	Therapeutics 05/2022 - 09/2003
5	Radiotherapy 06/2013 - 12/2003
4	Immunotherapy 05/2020 - 01/2013
4	Drug Therapy (Chemotherapy) 01/2020 - 04/2004
2	Precision Medicine 10/2016 - 02/2015
1	Aftercare (After-Treatment) 01/2021
1	Intravenous Injections 01/2015